Monthly Archives: April 2022

Dystrogen Therapeutics’ Investigational DT-DEC01 Chimeric Cell Therapy for the Treatment of Duchene Muscular Dystrophy Shows Improvements in Safety and Functionality | DNA RNA and Cells

Dystrogen Therapeutics’ Investigational DT-DEC01 Chimeric Cell Therapy for the Treatment of Duchene Muscular Dystrophy Shows Improvements in Safety and Functionality Details Category: DNA RNA and Cells Posted on Friday 08 April 2022 11:06 Hits: 388 Results continue to strengthen the safety and tolerability profile of DT-DEC01 The first …

Read More »